Merck's Goal: "One Less" Gardasil Marketing Problem

'Merck is trying to market its cervical cancer vaccine Gardasil to women who may not benefit from it after U.S. sales shrank in July and August, according to a Bloomberg article.Even though 75% of the most effective market for Gardasil (teenage girls from 13 to 17 years old) has not received a dose of Gardasil, Merck would rather focus on women ages 19 to 26, who have been less likely to get the shots than try to go after teenagers. "We see tremendous opportunity," said Bev Lybrand, Merck's senior vice president of vaccines. "We have a number of programs under way to get after these women."

Read more...